Risperdal Continues to Boggle Down Johnson & Johnson

Trouble is no stranger to Johnson & Johnson.  Johnson and Johnson (J&J), embroiled in massive litigation in DePuy ASR artificial hips, and in transvaginal mesh litigation from its Ethicon Gynecare products, faces more legal issues from its anti-psychotic drug, Risperdal.  Currently, Johnson & Johnson is appealing a 1.2 billion dollar fine issued in an Arkansas [...]